IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 204 filers reported holding IMMUNOGEN INC in Q4 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $163,261 | -89.8% | 42,516 | -87.3% | 0.00% | -90.0% |
| Q3 2022 | $1,603,000 | +2814.5% | 335,370 | +2640.6% | 0.01% | – |
| Q2 2022 | $55,000 | -6.8% | 12,237 | +16.8% | 0.00% | -100.0% |
| Q3 2021 | $59,000 | -83.2% | 10,476 | -80.3% | 0.00% | -75.0% |
| Q2 2021 | $351,000 | -41.9% | 53,228 | -28.6% | 0.00% | -60.0% |
| Q1 2021 | $604,000 | +310.9% | 74,588 | +227.0% | 0.01% | +400.0% |
| Q4 2020 | $147,000 | -64.8% | 22,811 | -74.9% | 0.00% | -66.7% |
| Q2 2020 | $418,000 | – | 90,783 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 17,503,417 | $277,779,228 | 13.22% |
| Fairmount Funds Management LLC | 5,929,592 | $94,102,625 | 11.32% |
| CM Management, LLC | 500,000 | $7,935,000 | 8.42% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 1,307,435 | $20,748,993 | 6.29% |
| Altium Capital Management LP | 725,000 | $11,505,750 | 6.00% |
| RA Capital Management | 13,322,288 | $211,424,711 | 4.16% |
| TANG CAPITAL MANAGEMENT LLC | 1,500,000 | $23,805,000 | 3.36% |
| BRIDGER MANAGEMENT, LLC | 467,220 | $7,414,781 | 2.73% |
| Birchview Capital, LP | 190,000 | $3,015,300 | 2.57% |
| Boxer Capital, LLC | 2,961,000 | $46,991,070 | 2.50% |